Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial - a primary care, type 2 diabetes study Article

Industry Collaboration

cited authors

  • Blonde, L.; Dagogo-Jack, S.; Banerji, M. A.; Pratley, R. E.; Marcellari, A.; Braceras, R.; Purkayastha, D.; Baron, M.

authors

Publication Date

  • October 1, 2009

webpage

published in

category

keywords

  • efficacy
  • primary care
  • safety
  • thiazolidinediones
  • vildagliptin

start page

  • 978

end page

  • 986

volume

  • 11

issue

  • 10